AZLI promising new inhaled antibiotic treatment helps

Dear Advocate,
Have you or someone you know had a personal experience using Aztreonam Lysine for Inhalation (AZLI)?

AZLI is a promising new inhaled antibiotic treatment that appears to help combat the pulmonary symptoms of cystic fibrosis.

By sharing your experience using AZLI, you can help the Foundation as it works with the Food and Drug Administration (FDA) to move this new therapy forward.
To help, simply:

Read our sample letter
Write about what AZLI has done for you
E-mail your letter to http://us.mc335.mail.yahoo.com/mc/compose?to=publicpolicy@cff.orgby November 28, 2008.

Read additional information about AZLI and the importance of the drug for treating CF.

Thank you for helping us work with the FDA to advance vital new treatments for cystic fibrosis. Cystic Fibrosis Foundation, 6931 Arlington Road, Bethesda, MD 20814 (800) FIGHT CFE-mail: publicpolicy@cff.org

Web: http://capwiz.com/cff/utr/1/AQNDJLXXXL/BXYIJLXZZZ/2644794626